RETRACTED: Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis
Saved in:
Main Authors: | Huiguang Xue, Aihua Yang, Fuguo Liu, Xueguo Sun, Xishuang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-06-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/2058739218781291 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels
by: Sun-Young Lee, et al.
Published: (2025-07-01) -
Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
by: Ya-kai Huang, et al.
Published: (2015-01-01) -
Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.
by: Teruhiko Terasawa, et al.
Published: (2014-01-01) -
In vitro gastrin-releasing peptide response in chicken ovarian follicles
by: Chunheng Mo, et al.
Published: (2025-08-01) -
Pepsinogen I as a marker of risk of gastric mucosal cell destruction in Helicobacter pylori-infected patients taking acetylsalicylic acid
by: I.G. Paliy, et al.
Published: (2025-06-01)